Trial Profile
A Phase III, Multi Center, Randomized, Placebo Controlled Study to Evaluate the Efficacy of the Combination Gefitinib With Thalidomide in Patients With Locally Advanced and Metastatic Non-Small-Cell-Lung-Cancer With EGFR Mutation
Status:
Not yet recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Gefitinib (Primary) ; Aspirin; Thalidomide
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 17 Mar 2015 New trial record